Hadland, Scott E and Park, Tae Woo and Bagley, Sarah M (2018) Stigma associated with medication treatment for young adults with opioid use disorder: a case series. Addiction Science & Clinical Practice , 13 , (15) . https://doi.org/10.1186/s13722-018-0116-2.
URL: https://ascpjournal.biomedcentral.com/articles/10....
Background: Opioid-related overdose deaths in the US have risen sharply among young adults. Despite this increase, access to evidence-based medication for opioid agonist treatment (OAT) for youth remains low. Among older adults, barriers to OAT include the paucity of buprenorphine-waivered prescribers and low rates of prescribing among waivered physicians. We have increasingly found in our clinical practice significant stigma related to using OAT to treat addiction for young adults. In this series, we describe three cases of young adults who faced significant stigma related to their treatment.
E Concepts in biomedical areas > Substance by legal status > Prescription drug (medicine / medication)
G Health and disease > Disorder by cause > Emotional trauma
HJ Treatment method > Substance disorder treatment method > Substance disorder drug therapy
J Health care, prevention and rehabilitation > Treatment and maintenance > Patient / client attitude toward treatment
J Health care, prevention and rehabilitation > Treatment and maintenance > Provider / worker / staff attitude toward treatment
MA-ML Social science, culture and community > Sociocultural discrimination concepts > Prejudice (stigma / discrimination)
T Demographic characteristics > Young adult
T Demographic characteristics > Young person who uses substances (user)
VA Geographic area > United States
Repository Staff Only: item control page